Liposomes encapsulating novel antimicrobial peptide Omiganan: Characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model-Reference-Cited by-同舟云学术

Liposomes encapsulating novel antimicrobial peptide Omiganan: Characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model

Published:2022-08 Issue: Volume:624 Page:122045
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Javia Ankit,Misra Ambikanandan,Thakkar Hetal

Funder

ICMR

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference74 articles.

1. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group;Alexander;Br. J. Dermatol.,2020

2. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003–2011;Armstrong;PLoS ONE,2012

3. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study;Arora;Expert opinion on drug delivery,2017

4. Overview of atopic dermatitis;Avena-Woods;The American journal of managed care,2017

5. Topical nano-encapsulated cyclosporine formulation for atopic dermatitis treatment;Badihi;Nanomed. Nanotechnol. Biol. Med.,2020

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Nanocarrier-based Approaches to Atopic Dermatitis and Emerging Trends in Drug Development and Design;Current Drug Delivery;2024-08

2. Advancing psoriasis drug delivery through topical liposomes;Zeitschrift für Naturforschung C;2024-07-23

3. A complex molecular landscape to drug delivery concept for achieving precise therapy in psoriasis;Medicine in Drug Discovery;2024-06

4. Pharmacokinetics study of ginsenoside Rg1 liposome by pulmonary administration;Heliyon;2024-05

5. Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles;Pharmaceutics;2024-03-25